BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 23066033)

  • 1. Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma.
    Das SK; Bhutia SK; Sokhi UK; Azab B; Su ZZ; Boukerche H; Anwar T; Moen EL; Chatterjee D; Pellecchia M; Sarkar D; Fisher PB
    Cancer Res; 2012 Dec; 72(23):6217-26. PubMed ID: 23066033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB.
    Boukerche H; Su ZZ; Emdad L; Sarkar D; Fisher PB
    Cancer Res; 2007 Feb; 67(4):1812-22. PubMed ID: 17308124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma.
    Notarbartolo M; Labbozzetta M; Pojero F; D'Alessandro N; Poma P
    Curr Mol Med; 2018; 18(9):630-639. PubMed ID: 30608040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDA-9/syntenin is essential for factor VIIa-induced signaling, migration, and metastasis in melanoma cells.
    Aissaoui H; Prévost C; Boucharaba A; Sanhadji K; Bordet JC; Négrier C; Boukerche H
    J Biol Chem; 2015 Feb; 290(6):3333-48. PubMed ID: 25505176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.
    Gangemi R; Mirisola V; Barisione G; Fabbi M; Brizzolara A; Lanza F; Mosci C; Salvi S; Gualco M; Truini M; Angelini G; Boccardo S; Cilli M; Airoldi I; Queirolo P; Jager MJ; Daga A; Pfeffer U; Ferrini S
    PLoS One; 2012; 7(1):e29989. PubMed ID: 22267972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src.
    Boukerche H; Su ZZ; Prévot C; Sarkar D; Fisher PB
    Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15914-9. PubMed ID: 18832467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression.
    Beshir AB; Ren G; Magpusao AN; Barone LM; Yeung KC; Fenteany G
    Cancer Lett; 2010 Dec; 299(2):137-49. PubMed ID: 20855151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin.
    Hwangbo C; Kim J; Lee JJ; Lee JH
    Cancer Res; 2010 Feb; 70(4):1645-55. PubMed ID: 20145126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB.
    Boukerche H; Aissaoui H; Prévost C; Hirbec H; Das SK; Su ZZ; Sarkar D; Fisher PB
    Oncogene; 2010 May; 29(21):3054-66. PubMed ID: 20228839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC‑1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity.
    Kim SO; Kim MR
    Int J Oncol; 2013 Jan; 42(1):349-58. PubMed ID: 23135610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mda-9/Syntenin: a positive regulator of melanoma metastasis.
    Boukerche H; Su ZZ; Emdad L; Baril P; Balme B; Thomas L; Randolph A; Valerie K; Sarkar D; Fisher PB
    Cancer Res; 2005 Dec; 65(23):10901-11. PubMed ID: 16322237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raf kinase inhibitor protein (RKIP) and phospho-RKIP expression in melanomas.
    Cardile V; Malaponte G; Loreto C; Libra M; Caggia S; Trovato FM; Musumeci G
    Acta Histochem; 2013 Oct; 115(8):795-802. PubMed ID: 23601922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer.
    Yousuf S; Duan M; Moen EL; Cross-Knorr S; Brilliant K; Bonavida B; LaValle T; Yeung KC; Al-Mulla F; Chin E; Chatterjee D
    PLoS One; 2014; 9(3):e92478. PubMed ID: 24658061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization.
    Baritaki S; Yeung K; Palladino M; Berenson J; Bonavida B
    Cancer Res; 2009 Nov; 69(21):8376-85. PubMed ID: 19843864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raf Kinase Inhibitor Protein (RKIP) Inhibits Tumor Necrosis Factor-α (TNF-α) Induced Adhesion Molecules Expression in Vascular Smooth Muscle Bells by Suppressing (Nuclear Transcription Factor-κB (NF-kappaB) Pathway.
    Jing SH; Gao X; Yu B; Qiao H
    Med Sci Monit; 2017 Oct; 23():4789-4797. PubMed ID: 28983072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RKIP Inhibits Local Breast Cancer Invasion by Antagonizing the Transcriptional Activation of MMP13.
    Datar I; Feng J; Qiu X; Lewandowski J; Yeung M; Ren G; Aras S; Al-Mulla F; Cui H; Trumbly R; Arudra SK; De Las Casas LE; de la Serna I; Bitar MS; Yeung KC
    PLoS One; 2015; 10(8):e0134494. PubMed ID: 26308852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines.
    Schuierer MM; Bataille F; Hagan S; Kolch W; Bosserhoff AK
    Cancer Res; 2004 Aug; 64(15):5186-92. PubMed ID: 15289323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RKIP downregulates B-Raf kinase activity in melanoma cancer cells.
    Park S; Yeung ML; Beach S; Shields JM; Yeung KC
    Oncogene; 2005 May; 24(21):3535-40. PubMed ID: 15782137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
    Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
    Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.